Table 1 Baseline characteristics
Baseline Characteristics | n | Vitamin D3 | n | Placebo | |
|---|---|---|---|---|---|
Included men | 151 | 49% | 156 | 51% | |
Age in years | 151 | 35 (6) | 156 | 35 (7) | |
BMI | 148 | 26.3 (4.0) | 151 | 26.4 (4.8) | |
Smokers | 37 | 27% | 31 | 22% | |
25(OH)D3 (nmol/L) | 147 | 46 (20) | 153 | 45 (20) | |
1,25(OH)2D3 (pmol/L) | 146 | 83 (31) | 151 | 85 (34) | |
PTH (pmol/L) | 117 | 4.5 (1.4) | 116 | 4.9 (1.6) | |
Hemoglobin (mmol/L) | 150 | 9.3 (0.6) | 150 | 9.3 (0.6) | |
Thrombocytes (109/L) | 150 | 230 (43) | 150 | 227 (44) | |
Leucocytes (109/L) | 150 | 6.1 (1.6) | 150 | 6.1 (2.0) | |
Neutrophils (109/L) | 150 | 3.2 (1.2) | 150 | 3.3 (1.5) | |
Basophils (109/L) | 150 | 0.035 (0.021) | 150 | 0.030 (0.019) | |
Eosinophils (109/L) | 150 | 0.22 (0.13) | 150 | 0.20 (0.15) | |
Monocytes (109/L) | 150 | 0.47 (0.14) | 150 | 0.46 (0.17) | |
Lymphocytes (109/L) | 150 | 2.01 (0.64) | 150 | 2.01 (0.62) | |
CRP (mg/L) | 150 | 1.6 (3.4) | 155 | 1.5 (2.8) | |
Ferritin (ug/L) | 150 | 181 (112) | 149 | 169 (93) | |
Orosomucoid (g/L) | 150 | 0.77 (0.17) | 149 | 0.77 (0.18) |